Acts Online
GT Shield

Labour Relations Act, 1995 (Act No. 66 of 1995)

Notices

National Bargaining Council for the Chemical Industry

Pharmaceutical Sector

Substantive Agreement 2025/2027

Extension to Non-parties of the Pharmaceutical Sector Collective Agreement

Chapter 3

9. Maternity Leave

 

9.1 Employees covered under the scope of this Agreement will be entitled to maternity leave of a maximum of 6 (six) months, during which leave a minimum of 75% of normal basic pay will be paid for the first 4 (four) months.

 

9.2 An employee who has a miscarriage during the third trimester of pregnancy, or bears a still - born child, will be entitled to sick leave if certified by a medical practitioner as incapable of working, and in addition will be entitled to 6 weeks special maternity leave during which leave a minimum of 75% of basic pay will be paid.

 

This is in addition to any maternity leave she may have already taken while still pregnant.

 

9.3 A female employee is entitled to apply for up to one day's paid special leave per month for ante and post-natal clinic visits (including visits to company clinics, in which case the minimum time off work will be taken, for a maximum of 3 months prior to and 3 months post birth.

 

9.4 Female employees in companies where existing Maternity Leave provisions are greater than the above will continue to be covered by existing Maternity Leave agreements/arrangements.

 

9.5 Specific conditions applying to maternity leave contained in existing plant level agreements will continue to apply.

 

9.6 An employee proceeding on maternity leave is guaranteed the right to return to the same job that she held before taking maternity leave.